History | Glecaprevir–pibrentasvir for treating chronic hepatitis C | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 224 KB)

Published:

24 January 2018

Final appraisal determination

Final appraisal determination
Public committee slides (PDF 583 KB)

Published:

07 December 2017
Final appraisal determination document (PDF 281 KB)

Published:

07 December 2017
Committee papers (PDF 12.32 MB)

Published:

07 December 2017

Invitation to participate

Final scope (PDF 284 KB)

Published:

31 May 2017
Final matrix (PDF 267 KB)

Published:

31 May 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 348 KB)

Published:

31 May 2017
Equality impact assessment (Scoping) (PDF 175 KB)

Published:

31 May 2017

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 294 KB)

Published:

07 June 2017
Draft matrix pre referral (PDF 264 KB)

Published:

07 June 2017